TLSI – trisalus life sciences, inc. (US:NASDAQ)
Stock Stats
News
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $12.00 to $11.00. They now have a "buy" rating on the stock.
TriSalus Reports Q3 2024 Financial Results and Provides Business Update [Yahoo! Finance]
TriSalus Reports Q3 2024 Financial Results and Provides Business Update
TriSalus Life Sciences Inc (TLSI) Q3 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Form 4 TriSalus Life Sciences, For: Nov 14 Filed by: Marshak Richard
Form 10-Q TriSalus Life Sciences, For: Sep 30
Form 8-K TriSalus Life Sciences, For: Nov 14
Form EFFECT TriSalus Life Sciences,
Form EFFECT TriSalus Life Sciences,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.